M055 PERTUBATION WITH LIGNOCAINE AS A NEW TREATMENT OF DYSMENORRHEA DUE TO ENDOMETRIOSIS: A RANDOMISED CONTROLLED TRIAL

Karin Wickström, Greta Edelstam
In: International Journal of Gynecology & Obstetrics · 2012 · vol. 119(S3) · doi:10.1016/s0020-7292(12)61249-1 · W2323288132
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This randomized controlled trial investigated the efficacy of M055 perturbation with lignocaine as a novel treatment for dysmenorrhea caused by endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosisdysmenorrhea

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-01T06:29:04.589233+00:00
License: CC0 · commercial use OK